The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Changes in perception of immunotherapy over time among patients with advanced genitourinary cancers.
 
Jasnoor Malhotra
No Relationships to Disclose
 
Errol James Philip
No Relationships to Disclose
 
Ameish Govindarajan
No Relationships to Disclose
 
Luis A Meza
No Relationships to Disclose
 
Zeynep Busra Zengin
No Relationships to Disclose
 
Sabrina Salgia
No Relationships to Disclose
 
Ramya Muddasani
Stock and Other Ownership Interests - Abbvie; Abbvie; Actinium Pharmaceuticals; Actinium Pharmaceuticals (I); Advaxis (I); Agenus; Agenus (I); Aprea Therapeutics; Aprea Therapeutics (I); Athenex (I); AVEO (I); Cellectar; Cellectar (I); crispr therapeutics (I); Curis (I); DelMar Pharmaceuticals; DelMar Pharmaceuticals (I); DelMar Pharmaceuticals (I); Epizyme; Epizyme (I); Forty Seven; Forty Seven (I); Gritstone Bio (I); Heat Biologics (I); Immunomedics; Immunomedics (I); Mereo BioPharma (I); NantHealth (I); NantKwest,; NantKwest, (I); Novavax (I); Onconova Therapeutics; Onconova Therapeutics (I); Pfizer (I); Portola Pharmaceuticals (I); Vaxart
 
Neal Shiv Chawla
No Relationships to Disclose
 
Daniela Castro
No Relationships to Disclose
 
Alex Chehrazi-Raffle
No Relationships to Disclose
 
Nazli Dizman
Consulting or Advisory Role - Vivreon Biosciences
 
Paulo Gustavo Bergerot
No Relationships to Disclose
 
Joann Hsu
No Relationships to Disclose
 
Tanya B. Dorff
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Janssen Oncology; Noxopharm; Seagen
Research Funding - Pfizer (Inst)
 
Sumanta K. Pal
Consulting or Advisory Role - F. Hoffmann LaRoche; F. Hoffmann LaRoche; Roche
Research Funding - Eisai (Inst); Exelixis (Inst); Genentech (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Genentech; Seagen
 
Cristiane Decat Bergerot
No Relationships to Disclose